Supernus Pharmaceuticals (SUPN) Q2 2014 Earnings

12MayConfirmed
Q3 2013
Q4 2013
Q1 2014
Q2 2014
-0.64
-0.54
-0.45
-0.35

Details

Expected EPS
-0.41
Actual EPS
-0.35
Surprise EPS
0.06
Surprise Percent
+14.63%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of -0.35 per share for Q2 2014.

0 Comments

Share your thoughts